Novavax, Inc. - Laporan Laba Rugi (TTM)

Novavax, Inc.
US ˙ NasdaqGS ˙ US6700024010

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Novavax, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 205 476 919 1,182 1,204 1,146 1,403 1,291 1,847 1,982 1,359 1,597 1,050 984 997 988 885 682 1,255 1,079
Change (%) 132.28 93.33 28.55 1.85 -4.77 22.40 -7.99 43.05 7.32 -31.44 17.55 -34.28 -6.29 1.31 -0.90 -10.38 -22.94 83.97 -14.04
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 375 747 1,323 1,859 1,973 2,535 2,341 2,331 2,661 2,071 2,020 1,698 1,198 1,037 906 796 770 570 522 462
Change (%) 99.12 77.08 40.51 6.14 28.48 -7.65 -0.43 14.19 -22.17 -2.46 -15.95 -29.43 -13.45 -12.62 -12.22 -3.25 -26.00 -8.29 -11.59
% of Revenue 183.23 157.07 143.87 157.25 163.88 221.11 166.82 180.53 144.11 104.51 148.69 106.31 114.16 105.44 90.94 80.55 86.96 83.51 41.63 42.82
Gross Operating Profit -170 -271 -403 -677 -769 -1,388 -937 -1,040 -815 -89 -662 -101 -149 -54 90 192 115 113 733 617
Change (%) 59.28 48.60 67.77 13.64 80.52 -32.47 10.89 -21.65 -89.02 639.34 -84.76 47.43 -63.97 -268.52 112.86 -39.90 -2.55 551.04 -15.79
% of Revenue -83.23 -57.07 -43.87 -57.25 -63.88 -121.11 -66.82 -80.53 -44.11 -4.51 -48.69 -6.31 -14.16 -5.44 9.06 19.45 13.04 16.49 58.37 57.18
SG&A 92 143 196 252 273 298 331 366 411 489 505 513 464 457 427 437 405 324 289 230
Change (%) 54.72 37.74 28.23 8.30 9.39 10.99 10.57 12.31 18.83 3.38 1.51 -9.55 -1.39 -6.61 2.32 -7.24 -20.20 -10.73 -20.52
% of Revenue 45.01 29.98 21.36 21.31 22.66 26.03 23.60 28.36 22.27 24.66 37.18 32.11 44.19 46.50 42.87 44.26 45.81 47.44 23.02 21.29
R&D 67 41 41 41 21 21 21
Change (%) 0.00 0.00 0.00 0.00
% of Revenue 3.36 4.19 4.14 4.17 3.06 1.66 1.93
OpEx 467 890 1,519 2,110 2,246 2,833 2,672 2,697 3,073 2,627 2,526 2,211 1,662 1,536 1,375 1,274 1,175 914 832 712
Change (%) 90.36 70.77 38.92 6.40 26.16 -5.69 0.94 13.93 -14.51 -3.84 -12.46 -24.82 -7.60 -10.49 -7.34 -7.75 -22.22 -8.96 -14.40
% of Revenue 228.24 187.05 165.23 178.56 186.54 247.13 190.42 208.90 166.38 132.53 185.87 138.42 158.35 156.14 137.95 128.98 132.76 134.00 66.31 66.04
Operating Income -263 -414 -600 -929 -1,042 -1,687 -1,269 -1,406 -1,226 -645 -1,167 -614 -613 -552 -378 -286 -290 -232 423 366
Change (%) 57.68 44.86 54.82 12.19 61.90 -24.78 10.81 -12.80 -47.40 80.97 -47.40 -0.19 -9.85 -31.52 -24.31 1.32 -20.03 -282.30 -13.35
% of Revenue -128.24 -87.05 -65.23 -78.56 -86.54 -147.13 -90.42 -108.90 -66.38 -32.53 -85.87 -38.42 -58.35 -56.14 -37.95 -28.98 -32.76 -34.00 33.69 33.96
Interest Expense -15 -15 -17 -19 -20 -21 -21 -21 -20 -20 -19 -16 -15 -14 -14 -15 -17 -20 -22 -24
Change (%) 3.24 9.48 15.47 3.77 6.34 0.18 1.26 -4.73 -2.63 -2.82 -16.10 -8.08 -3.25 -1.42 7.17 9.04 20.88 8.03 8.65
% of Revenue -7.16 -3.18 -1.80 -1.62 -1.65 -1.84 -1.51 -1.66 -1.11 -1.00 -1.42 -1.01 -1.42 -1.47 -1.43 -1.54 -1.88 -2.94 -1.73 -2.18
Net Income -273 -418 -615 -950 -1,075 -1,744 -1,318 -1,476 -1,322 -658 -1,155 -587 -549 -545 -399 -294 -285 -187 479 423
Change (%) 53.48 47.07 54.43 13.17 62.20 -24.44 12.00 -10.42 -50.23 75.59 -49.21 -6.45 -0.70 -26.85 -26.18 -3.22 -34.18 -355.31 -11.67
% of Revenue -133.10 -87.94 -66.90 -80.37 -89.31 -152.12 -93.91 -114.32 -71.59 -33.20 -85.02 -36.73 -52.29 -55.41 -40.01 -29.80 -32.18 -27.49 38.14 39.20

Source: Capital IQ

Other Listings
MX:NVAX
AT:NVAX
GB:0A3S US$ 7.79
DE:NVV1 € 6.66
BG:NVV1
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista